메뉴 건너뛰기




Volumn 50, Issue 1, 2015, Pages 121-126

GVHD prophylaxis with sirolimus-tacrolimus may overcome the deleterious effect on survival of HLA mismatch after reduced-intensity conditioning allo-SCT

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; FLUDARABINE; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DRB1 ANTIGEN; MELPHALAN; RAPAMYCIN; TACROLIMUS; THIOTEPA; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT;

EID: 84920628434     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2014.220     Document Type: Article
Times cited : (8)

References (35)
  • 1
    • 37349118061 scopus 로고    scopus 로고
    • High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation
    • Lee SJ, Klein J, Haagenson M, Baxter-Lowe LA, Confer DL, Eapen M et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007; 110: 4576-4583.
    • (2007) Blood , vol.110 , pp. 4576-4583
    • Lee, S.J.1    Klein, J.2    Haagenson, M.3    Baxter-Lowe, L.A.4    Confer, D.L.5    Eapen, M.6
  • 2
    • 84887389178 scopus 로고    scopus 로고
    • Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS)
    • Saber W, Cutler CS, Nakamura R, Zhang MJ, Atallah E, Rizzo JD et al. Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS). Blood 2013; 122: 1974-1982.
    • (2013) Blood , vol.122 , pp. 1974-1982
    • Saber, W.1    Cutler, C.S.2    Nakamura, R.3    Zhang, M.J.4    Atallah, E.5    Rizzo, J.D.6
  • 3
    • 79955985682 scopus 로고    scopus 로고
    • HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation
    • Woolfrey A, Klein JP, Haagenson M, Spellman S, Petersdorf E, Oudshoorn M et al. HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 2011; 17: 885-892.
    • (2011) Biol Blood Marrow Transplant , vol.17 , pp. 885-892
    • Woolfrey, A.1    Klein, J.P.2    Haagenson, M.3    Spellman, S.4    Petersdorf, E.5    Oudshoorn, M.6
  • 4
    • 44649167561 scopus 로고    scopus 로고
    • Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: Revised definitions to predict survival
    • Weisdorf D, Spellman S, Haagenson M, Horowitz M, Lee S, Anasetti C et al. Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival. Biol Blood Marrow Transplant 2008; 14: 748-758.
    • (2008) Biol Blood Marrow Transplant , vol.14 , pp. 748-758
    • Weisdorf, D.1    Spellman, S.2    Haagenson, M.3    Horowitz, M.4    Lee, S.5    Anasetti, C.6
  • 5
    • 79960323788 scopus 로고    scopus 로고
    • ATG prevents severe acute graft-versus-host disease in mismatched unrelated donor hematopoietic cell transplantation
    • Pidala J, Tomblyn M, Nishihori T, Ayala E, Field T, Fernandez H et al. ATG prevents severe acute graft-versus-host disease in mismatched unrelated donor hematopoietic cell transplantation. Biol Blood Marrow Transplant 2011; 17: 1237-1244.
    • (2011) Biol Blood Marrow Transplant , vol.17 , pp. 1237-1244
    • Pidala, J.1    Tomblyn, M.2    Nishihori, T.3    Ayala, E.4    Field, T.5    Fernandez, H.6
  • 6
    • 78851471997 scopus 로고    scopus 로고
    • In vivo T-cell depletion with pretransplant low-dose antithymocyte globulin is associated with reduced transplant-related mortality and improved clinical outcome in patients receiving allogeneic hematopoietic stem cell transplantation from unrelated and partially matched related donors
    • Busca A, Locatelli F, Flonta SE, Ciccone G, Baldi I, D'Ardia S et al. In vivo T-cell depletion with pretransplant low-dose antithymocyte globulin is associated with reduced transplant-related mortality and improved clinical outcome in patients receiving allogeneic hematopoietic stem cell transplantation from unrelated and partially matched related donors. Am J Hematol 2011; 86: 214-217.
    • (2011) Am J Hematol , vol.86 , pp. 214-217
    • Busca, A.1    Locatelli, F.2    Flonta, S.E.3    Ciccone, G.4    Baldi, I.5    D'Ardia, S.6
  • 7
    • 84858072312 scopus 로고    scopus 로고
    • Quality of life of patients after allogeneic hematopoietic stem cell transplantation with antihuman thymocyte globulin
    • Yu ZP, Ding JH, Wu F, Liu J, Wang J, Cheng J et al. Quality of life of patients after allogeneic hematopoietic stem cell transplantation with antihuman thymocyte globulin. Biol Blood Marrow Transplant 2012; 18: 593-599.
    • (2012) Biol Blood Marrow Transplant , vol.18 , pp. 593-599
    • Yu, Z.P.1    Ding, J.H.2    Wu, F.3    Liu, J.4    Wang, J.5    Cheng, J.6
  • 8
    • 79959456118 scopus 로고    scopus 로고
    • Chronic graft-versus-host disease: Long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius
    • Socié G, Schmoor C, Bethge WA, Ottinger HD, Stelljes M, Zander AR et al. Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius. Blood 2011; 117: 6375-6382.
    • (2011) Blood , vol.117 , pp. 6375-6382
    • Socié, G.1    Schmoor, C.2    Bethge, W.A.3    Ottinger, H.D.4    Stelljes, M.5    Zander, A.R.6
  • 9
    • 84891885113 scopus 로고    scopus 로고
    • Effective prevention of GVHD using in vivo T-cell depletion with anti-lymphocyte globulin in HLA-identical or -mismatched sibling peripheral blood stem cell transplantation
    • Wolschke C, Zabelina T, Ayuk F, Alchalby H, Berger J, Klyuchnikov E et al. Effective prevention of GVHD using in vivo T-cell depletion with anti-lymphocyte globulin in HLA-identical or -mismatched sibling peripheral blood stem cell transplantation. Bone Marrow Transplant 2014; 49: 126-130.
    • (2014) Bone Marrow Transplant , vol.49 , pp. 126-130
    • Wolschke, C.1    Zabelina, T.2    Ayuk, F.3    Alchalby, H.4    Berger, J.5    Klyuchnikov, E.6
  • 10
    • 79955129544 scopus 로고    scopus 로고
    • Clinical effect of reduced-intensity conditioning regimen containing antithymocyte globulin for hematopoietic cell transplantation from unrelated-donors
    • Lee KH, Choi SJ, Lee JH, Lee JH, Kim DY, Seol M et al. Clinical effect of reduced-intensity conditioning regimen containing antithymocyte globulin for hematopoietic cell transplantation from unrelated-donors. Am J Hematol 2011; 86: 399-405.
    • (2011) Am J Hematol , vol.86 , pp. 399-405
    • Lee, K.H.1    Choi, S.J.2    Lee, J.H.3    Lee, J.H.4    Kim, D.Y.5    Seol, M.6
  • 11
    • 84876085522 scopus 로고    scopus 로고
    • Long-term outcomes of antithymocyte globulin in patients with hematological malignancies undergoing myeloablative allogeneic hematopoietic cell transplantation: A systematic review and meta-analysis
    • Du K, Hu Y, Wu K, Huang H. Long-term outcomes of antithymocyte globulin in patients with hematological malignancies undergoing myeloablative allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis. Clin Transplant 2013; 27: E91-E100.
    • (2013) Clin Transplant , vol.27 , pp. E91-E100
    • Du, K.1    Hu, Y.2    Wu, K.3    Huang, H.4
  • 12
    • 0041941520 scopus 로고    scopus 로고
    • Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation
    • Antin JH, Kim HT, Cutler C, Ho VT, Lee SJ, Miklos DB et al. Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation. Blood 2003; 102: 1601-1605.
    • (2003) Blood , vol.102 , pp. 1601-1605
    • Antin, J.H.1    Kim, H.T.2    Cutler, C.3    Ho, V.T.4    Lee, S.J.5    Miklos, D.B.6
  • 13
    • 47249151462 scopus 로고    scopus 로고
    • Sirolimus, tacrolimus, and low-dose methotrexate as graft-versus-host disease prophylaxis in related and unrelated donor reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation
    • Alyea EP, Li S, Kim HT, Cutler C, Ho V, Soiffer RJ et al. Sirolimus, tacrolimus, and low-dose methotrexate as graft-versus-host disease prophylaxis in related and unrelated donor reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 2008; 14: 920-926.
    • (2008) Biol Blood Marrow Transplant , vol.14 , pp. 920-926
    • Alyea, E.P.1    Li, S.2    Kim, H.T.3    Cutler, C.4    Ho, V.5    Soiffer, R.J.6
  • 14
    • 33947578933 scopus 로고    scopus 로고
    • Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation
    • Cutler C, Li S, Ho VT, Koreth J, Alyea E, Soiffer RJ et al. Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation. Blood 2007; 109: 3108-3114.
    • (2007) Blood , vol.109 , pp. 3108-3114
    • Cutler, C.1    Li, S.2    Ho, V.T.3    Koreth, J.4    Alyea, E.5    Soiffer, R.J.6
  • 15
    • 41849148993 scopus 로고    scopus 로고
    • Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donors
    • Furlong T, Kiem HP, Appelbaum FR, Carpenter PA, Deeg HJ, Doney K et al. Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donors. Biol Blood Marrow Transplant 2008; 14: 531-537.
    • (2008) Biol Blood Marrow Transplant , vol.14 , pp. 531-537
    • Furlong, T.1    Kiem, H.P.2    Appelbaum, F.R.3    Carpenter, P.A.4    Deeg, H.J.5    Doney, K.6
  • 16
    • 77958553914 scopus 로고    scopus 로고
    • Sirolimus immunosuppression for graft-versus-host disease prophylaxis and therapy: An update
    • Cutler C, Antin JH. Sirolimus immunosuppression for graft-versus-host disease prophylaxis and therapy: an update. Curr Opin Hematol 2010; 17: 500-504.
    • (2010) Curr Opin Hematol , vol.17 , pp. 500-504
    • Cutler, C.1    Antin, J.H.2
  • 17
    • 84875680385 scopus 로고    scopus 로고
    • The combination of sirolimus plus tacrolimus improves outcome after reducedintensity conditioning, unrelated donor hematopoietic stem cell transplantation compared with cyclosporine plus mycofenolate
    • Perez-Simón JA, Martino R, Parody R, Cabrero M, Lopez-Corral L, Valcarcel D et al. The combination of sirolimus plus tacrolimus improves outcome after reducedintensity conditioning, unrelated donor hematopoietic stem cell transplantation compared with cyclosporine plus mycofenolate. Haematologica 2013; 98: 526-532.
    • (2013) Haematologica , vol.98 , pp. 526-532
    • Perez-Simón, J.A.1    Martino, R.2    Parody, R.3    Cabrero, M.4    Lopez-Corral, L.5    Valcarcel, D.6
  • 19
    • 0025070398 scopus 로고
    • Chronic graft-versus-host disease
    • Sullivan KM. Chronic graft-versus-host disease. Cancer Treat Res 1990; 50: 79-98.
    • (1990) Cancer Treat Res , vol.50 , pp. 79-98
    • Sullivan, K.M.1
  • 20
    • 0021363719 scopus 로고
    • Venocclusive disease of the liver after bone marrow transplantation: Diagnosis, incidence, and predisposing factors
    • McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED. Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology 1984; 4: 116-122.
    • (1984) Hepatology , vol.4 , pp. 116-122
    • McDonald, G.B.1    Sharma, P.2    Matthews, D.E.3    Shulman, H.M.4    Thomas, E.D.5
  • 21
    • 34948887692 scopus 로고    scopus 로고
    • Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: Real progress or are we still waiting?
    • Batts ED, Lazarus HM. Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?. Bone Marrow Transplant 2007; 40: 709-719.
    • (2007) Bone Marrow Transplant , vol.40 , pp. 709-719
    • Batts, E.D.1    Lazarus, H.M.2
  • 22
    • 46249126149 scopus 로고    scopus 로고
    • Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
    • De Paw B, Waksh TJ, Donelly P, Stevens DA, Edwards JE, Calandra T et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-1821.
    • (2008) Clin Infect Dis , vol.46 , pp. 1813-1821
    • De Paw, B.1    Waksh, T.J.2    Donelly, P.3    Stevens, D.A.4    Edwards, J.E.5    Calandra, T.6
  • 23
    • 0000120995 scopus 로고
    • A class of K-sample tests for comparing the cumulative incidence of a competing risk
    • Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16: 1140-1154.
    • (1988) Ann Stat , vol.16 , pp. 1140-1154
    • Gray, R.J.1
  • 24
    • 81255172445 scopus 로고    scopus 로고
    • Donor characteristics affecting graft failure, graft vs host disease and survival after unrelated donor transplantation with reduced intensity conditioning for hematologic malignancies
    • Passweg JR, Zhang MJ, Rocha V, Kan F, Champlin RE, Isola LM et al. Donor characteristics affecting graft failure, graft vs. host disease and survival after unrelated donor transplantation with reduced intensity conditioning for hematologic malignancies. Biol Blood Marrow Transplant 2011; 17: 1869-1873.
    • (2011) Biol Blood Marrow Transplant , vol.17 , pp. 1869-1873
    • Passweg, J.R.1    Zhang, M.J.2    Rocha, V.3    Kan, F.4    Champlin, R.E.5    Isola, L.M.6
  • 25
    • 0037318188 scopus 로고    scopus 로고
    • Matched and mismatched allogeneic stem-cell transplantation from unrelated donors using combined graft-versus-host disease prophylaxis including rabbit anti-T lymphocyte globulin
    • Finke J, Schmoor C, Lang H, Potthoff K, Bertz H. Matched and mismatched allogeneic stem-cell transplantation from unrelated donors using combined graft-versus-host disease prophylaxis including rabbit anti-T lymphocyte globulin. J Clin Oncol 2003; 21: 506-513.
    • (2003) J Clin Oncol , vol.21 , pp. 506-513
    • Finke, J.1    Schmoor, C.2    Lang, H.3    Potthoff, K.4    Bertz, H.5
  • 26
    • 84867404950 scopus 로고    scopus 로고
    • Prognostic factors affecting outcome after allogeneic transplantation for hematological malignancies from unrelated donors: Results from a randomized trial
    • Finke J, Schmoor C, Bethge WA, Ottinger HD, Stelljes M, Zander AR et al. Prognostic factors affecting outcome after allogeneic transplantation for hematological malignancies from unrelated donors: results from a randomized trial. Biol Blood Marrow Transplant 2012; 18: 1716-1726.
    • (2012) Biol Blood Marrow Transplant , vol.18 , pp. 1716-1726
    • Finke, J.1    Schmoor, C.2    Bethge, W.A.3    Ottinger, H.D.4    Stelljes, M.5    Zander, A.R.6
  • 27
    • 84867444863 scopus 로고    scopus 로고
    • Anti-thymocyte globulin (thymoglobulin), tacrolimus, and sirolimus as acute graft-versus-host disease prophylaxis for unrelated hematopoietic stem cell transplantation
    • Al-Kadhimi Z, Gul Z, Rodriguez R, Chen W, Smith D, Mitchell A et al. Anti-thymocyte globulin (thymoglobulin), tacrolimus, and sirolimus as acute graft-versus-host disease prophylaxis for unrelated hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2012; 18: 1734-1744.
    • (2012) Biol Blood Marrow Transplant , vol.18 , pp. 1734-1744
    • Al-Kadhimi, Z.1    Gul, Z.2    Rodriguez, R.3    Chen, W.4    Smith, D.5    Mitchell, A.6
  • 28
    • 84873457670 scopus 로고    scopus 로고
    • A phase II study of sirolimus, tacrolimus and rabbit anti-thymocyte globulin as GVHD prophylaxis after unrelated-donor PBSC transplant
    • Khaled SK, Palmer J, Stiller T, Senitzer D, Maegawa R, Rodriguez R et al. A phase II study of sirolimus, tacrolimus and rabbit anti-thymocyte globulin as GVHD prophylaxis after unrelated-donor PBSC transplant. Bone Marrow Transplant 2013; 48: 278-283.
    • (2013) Bone Marrow Transplant , vol.48 , pp. 278-283
    • Khaled, S.K.1    Palmer, J.2    Stiller, T.3    Senitzer, D.4    Maegawa, R.5    Rodriguez, R.6
  • 29
    • 31544468676 scopus 로고    scopus 로고
    • HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants
    • Shaw BE, Marsh SG, Mayor NP, Russell NH, Madrigal JA. HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants. Blood 2006; 107: 1220-1226.
    • (2006) Blood , vol.107 , pp. 1220-1226
    • Shaw, B.E.1    Marsh, S.G.2    Mayor, N.P.3    Russell, N.H.4    Madrigal, J.A.5
  • 30
    • 84870819921 scopus 로고    scopus 로고
    • Anti-thymocyte globulin for conditioning in matched unrelated donor hematopoietic cell transplantation provides comparable outcomes to matched related donor recipients
    • Portier DA, Sabo RT, Roberts CH, Fletcher DS, Meier J, Clark WB et al. Anti-thymocyte globulin for conditioning in matched unrelated donor hematopoietic cell transplantation provides comparable outcomes to matched related donor recipients. Bone Marrow Transplant 2012; 47: 1513-1519.
    • (2012) Bone Marrow Transplant , vol.47 , pp. 1513-1519
    • Portier, D.A.1    Sabo, R.T.2    Roberts, C.H.3    Fletcher, D.S.4    Meier, J.5    Clark, W.B.6
  • 31
    • 77649224551 scopus 로고    scopus 로고
    • A phase II pilot study of Tacrolimus/Sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens
    • Rodriguez R, Nakamura R, Palmer JM, Parker P, Shayani S, Nademanee A et al. A phase II pilot study of Tacrolimus/Sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens. Blood 2010; 115: 1098-1105.
    • (2010) Blood , vol.115 , pp. 1098-1105
    • Rodriguez, R.1    Nakamura, R.2    Palmer, J.M.3    Parker, P.4    Shayani, S.5    Nademanee, A.6
  • 32
    • 11144354152 scopus 로고    scopus 로고
    • Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation
    • Cutler C, Kim HT, Hochberg E, Ho V, Alyea E, Lee SJ et al. Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 2004; 10: 328-336.
    • (2004) Biol Blood Marrow Transplant , vol.10 , pp. 328-336
    • Cutler, C.1    Kim, H.T.2    Hochberg, E.3    Ho, V.4    Alyea, E.5    Lee, S.J.6
  • 33
    • 66949177968 scopus 로고    scopus 로고
    • Comparison of tacrolimus and sirolimus (Tac/Sir) versus tacrolimus, sirolimus, and minimethotrexate (Tac/Sir/MTX) as acute graft-versus-host disease prophylaxis after reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation
    • Ho VT, Aldridge J, Kim HT, Cutler C, Koreth J, Armand P et al. Comparison of tacrolimus and sirolimus (Tac/Sir) versus tacrolimus, sirolimus, and minimethotrexate (Tac/Sir/MTX) as acute graft-versus-host disease prophylaxis after reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 2009; 15: 844-850.
    • (2009) Biol Blood Marrow Transplant , vol.15 , pp. 844-850
    • Ho, V.T.1    Aldridge, J.2    Kim, H.T.3    Cutler, C.4    Koreth, J.5    Armand, P.6
  • 34
    • 84920625699 scopus 로고    scopus 로고
    • The addition of sirolimus to the GVHD prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: A multicenter tandomized trial
    • Abstract 704
    • Armand P, Kim HT, Sainvil M, Bachanova V, Devine SM, Waller EK et al. The addition of sirolimus to the GVHD prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicenter tandomized trial. American Society of Haematology 2013; Abstract 704.
    • (2013) American Society of Haematology
    • Armand, P.1    Kim, H.T.2    Sainvil, M.3    Bachanova, V.4    Devine, S.M.5    Waller, E.K.6
  • 35
    • 58149388343 scopus 로고    scopus 로고
    • Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation
    • Cutler C, Stevenson K, Kim HT, Richardson P, Ho VT, Linden E et al. Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation. Blood 2008; 112: 4425-4431.
    • (2008) Blood , vol.112 , pp. 4425-4431
    • Cutler, C.1    Stevenson, K.2    Kim, H.T.3    Richardson, P.4    Ho, V.T.5    Linden, E.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.